Patents by Inventor Piet Tom Bert Paul Wigerinck

Piet Tom Bert Paul Wigerinck has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20210179631
    Abstract: New pseudopolymorphic forms of (3R,3aS,6aR)-hexahydrofuro [2,3-b] furan-3-yl (1S,2R)-3-[[(4-aminophenyl) sulfonyl] (isobutyl) amino]-1-benzyl-2-hydroxypropylcarbamate and processes for producing them are disclosed.
    Type: Application
    Filed: October 30, 2020
    Publication date: June 17, 2021
    Inventors: Hans Wim Pieter Vermeersch, Daniel Joseph Christiaan Thone, Luc Donne Marie-Louise Janssens, Piet Tom Bert Paul Wigerinck
  • Patent number: 10858369
    Abstract: New pseudopolymorphic forms of (3R,3aS,6aR)-hexahydrofuro [2,3-b] furan-3-yl (1S,2R)-3-[[(4-aminophenyl) sulfonyl] isobutyl) amino]-1-benzyl-2-hydroxypropylcarbamate and processes for producing them are disclosed.
    Type: Grant
    Filed: May 16, 2018
    Date of Patent: December 8, 2020
    Assignee: Janssen Sciences Ireland Unlimited Company
    Inventors: Hans Wim Pieter Vermeersch, Daniel Joseph Christiaan Thone, Luc Donne Marie-Louise Janssens, Piet Tom Bert Paul Wigerinck
  • Patent number: 10376520
    Abstract: The present invention discloses compounds according to Formula (I): or a pharmaceutically acceptable salt thereof, or a solvate or the salt of a solvate thereof, pharmaceutical compositions comprising the same, and methods of treatment using the same, for use in the prophylaxis and/or treatment of cardiovascular disorders and/or dyslipidemia, by administering the compound according to Formula (I).
    Type: Grant
    Filed: March 31, 2016
    Date of Patent: August 13, 2019
    Assignee: GALAPAGOS NV
    Inventors: Piet Tom Bert Paul Wigerinck, Gerben Albert Eleutherius Van 'T Klooster
  • Publication number: 20180312517
    Abstract: New pseudopolymorphic forms of (3R,3aS,6aR)-hexahydrofuro [2,3-b] furan-3-yl (1S,2R)-3-[[(4-aminophenyl) sulfonyl] isobutyl) amino]-1-benzyl-2-hydroxypropylcarbamate and processes for producing them are disclosed.
    Type: Application
    Filed: May 16, 2018
    Publication date: November 1, 2018
    Inventors: Hans Wim Pieter Vermeersch, Daniel Joseph Christiaan Thone, Luc Donne Marie-Louise Janssens, Piet Tom Bert Paul Wigerinck
  • Publication number: 20180200257
    Abstract: The present invention discloses compounds according to Formula I; or a pharmaceutically acceptable salt thereof, or a solvate or the salt of a solvate thereof, pharmaceutical compositions comprising the same, and methods of treatment using the same, for use in the treatment of inflammatory conditions, by administering the compound according to Formula I.
    Type: Application
    Filed: March 31, 2016
    Publication date: July 19, 2018
    Inventors: Piet Tom Bert Paul Wigerinck, Gerben Albert Eleutherius Van 'T Klooster, Frederic Paul Vanhoutte
  • Publication number: 20180185377
    Abstract: The present invention discloses compounds according to Formula (I): or a pharmaceutically acceptable salt thereof, or a solvate or the salt of a solvate thereof, pharmaceutical compositions comprising the same, and methods of treatment using the same, for use in the prophylaxis and/or treatment of cardiovascular disorders and/or dyslipidemia, by administering the compound according to Formula (I).
    Type: Application
    Filed: March 31, 2016
    Publication date: July 5, 2018
    Inventors: Piet Tom Bert Paul Wigerinck, Gerben Albert Eleutherius Van 'T Klooster
  • Patent number: 10000504
    Abstract: New pseudopolymorphic forms of (3R,3aS,6aR)-hexahydrofuro [2,3-b] furan-3-yl (1S,2R)-3-[[(4-aminophenyl) sulfonyl] (isobutyl) amino]-1-benzyl-2-hydroxypropylcarbamate and processes for producing them are disclosed.
    Type: Grant
    Filed: May 22, 2017
    Date of Patent: June 19, 2018
    Assignee: Janssen Sciences Ireland UC
    Inventors: Hans Wim Pieter Vermeersch, Daniel Joseph Christiaan Thone, Luc Donne Marie-Louise Janssens, Piet Tom Bert Paul Wigerinck
  • Publication number: 20170260196
    Abstract: New pseudopolymorphic forms of (3R,3aS,6aR)-hexahydrofuro [2,3-b] furan-3-yl (1S,2R)-3-[[(4-aminophenyl) sulfonyl] (isobutyl) amino]-1-benzyl-2-hydroxypropylcarbamate and processes for producing them are disclosed.
    Type: Application
    Filed: May 22, 2017
    Publication date: September 14, 2017
    Inventors: Hans Wim Pieter Vermeersch, Daniel Joseph Christiaan Thone, Luc Donne Marie-Louise Janssens, Piet Tom Bert Paul Wigerinck
  • Publication number: 20150336980
    Abstract: New pseudopolymorphic forms of (3R,3aS,6aR)-hexahydrofuro[2,3-b]furan-3-yl(1S,2R)-3-[[(4-aminophenyl)sulfonyl](isobutyl)amino]-1-benzyl-2-hydroxypropylcarbamate and processes for producing them are disclosed.
    Type: Application
    Filed: August 4, 2015
    Publication date: November 26, 2015
    Inventors: Hans Wim Pieter VERMEERSCH, Daniel Joseph Christiaan THONE, Luc Donne Marie-Louise JANSSENS, Piet Tom Bert Paul WIGERINCK
  • Publication number: 20140171499
    Abstract: New pseudopolymorphic forms of (3R,3aS,6aR)-hexahydrofuro[2,3-b]furan-3-yl(1S,2R)-3-[[(4-aminophenyl)sulfonyl](isobutyl)amino]-1-benzyl-2-hydroxypropylcarbamate and processes for producing them are disclosed.
    Type: Application
    Filed: February 19, 2014
    Publication date: June 19, 2014
    Applicant: Janssen R&D Ireland
    Inventors: Hans Wim Pieter VERMEERSCH, Daniel Joseph Christiaan THONE, Luc Donne Marie-Louise JANSSENS, Piet Tom Bert Paul WIGERINCK
  • Publication number: 20130303790
    Abstract: New pseudopolymorphic forms of (3R,3aS,6aR)-hexahydrofuro[2,3-b]furan-3-yl(1S,2R)-3-[[(4-aminophenyl)sulfonyl](isobutyl)amino]-1-benzyl-2-hydroxypropylcarbamate and processes for producing them are disclosed.
    Type: Application
    Filed: July 11, 2013
    Publication date: November 14, 2013
    Inventors: Hans Wim Pieter VERMEERSCH, Daniel Joseph Christiaan Thone, Luc Donne Marie-Louise Janssens, Piet Tom Bert Paul Wigerinck
  • Patent number: 8580981
    Abstract: The present invention relates to a process for the preparation of (3R,3aS,6aR)-hexahydrofuro[2,3-b]furan-3-yl(1S,2R)-3-[[(4-aminophenyl)sulfonyl](isobutyl)amino]-1-benzyl-2-hydroxypropylcarbamate as well as novel intermediates for use in said process. (3R,3aS,6aR)-hexahydrofuro[2,3-b]furan-3-yl(1S,2R)-3-[[(4-aminophenyl)sulfonyl](isobutyl)amino]-1-benzyl-2-hydroxypropylcarbamate is particularly useful as an HIV protease inhibitor.
    Type: Grant
    Filed: September 1, 2009
    Date of Patent: November 12, 2013
    Assignee: Janssen R&D Ireland
    Inventors: Piet Tom Bert Paul Wigerinck, Dominique Louis Nestor Ghislain Surleraux, Wim Gaston Verschueren, Herman Augustinus De Kock, Wim Albert Alex Aelterman
  • Patent number: 8557854
    Abstract: A method for improving the pharmacokinetics of drugs, which are metabolized by cytochrome P450 monooxygenase is disclosed. More specifically it relates to a method for improving the pharmacokinetics of retroviral protease inhibitors and in particular for improving the pharmacokinetics of human immunodeficiency virus (HIV) protease inhibitors. A pharmaceutical composition and its use in the manufacture of a medicament for the inhibition or treatment of an HIV infection or AIDS in a human being are also part of the invention.
    Type: Grant
    Filed: April 14, 2006
    Date of Patent: October 15, 2013
    Assignee: Janssen R&D Ireland
    Inventors: Gerben Albert Van 'T Klooster, Piet Tom Bert Paul Wigerinck, Sandra De Meyer, Lieven Elvire Colette Baert, Herman Augustinus De Kock
  • Patent number: 8518987
    Abstract: New pseudopolymorphic forms of (3R,3aS,6aR)-hexahydrofuro[2,3-b]furan-3-yl (1S,2R)-3-[[(4-aminophenyl)sulfonyl](isobutyl)amino]-1-benzyl-2-hydroxypropylcarbamate and processes for producing them are disclosed.
    Type: Grant
    Filed: August 6, 2009
    Date of Patent: August 27, 2013
    Assignee: Janssen R&D Ireland
    Inventors: Hans Wim Pieter Vermeersch, Daniel Joseph Christiaan Thone, Luc Donne Marie-Louise Janssens, Piet Tom Bert Paul Wigerinck
  • Patent number: 8383608
    Abstract: Novel compounds are disclosed that have a Formula represented by the following: wherein X, R1, R2a, R2b, R2c, R3a R3b, R4a, R4b, R4c, and m1 are as described herein. The compounds may be prepared as pharmaceutical compositions, and may be used for the prevention and treatment of a variety of conditions in mammals including humans, including by way of non-limiting example, cachexia, osteoporosis, sarcopenia, a decline in libido and/or sexual dysfunction.
    Type: Grant
    Filed: June 23, 2011
    Date of Patent: February 26, 2013
    Inventors: François Nique, Catherine Jagerschmidt, Florence Sylvie Namour, Roland Blanqué, Jean-Michel Lefrançois, Christophe Peixoto, Pierre Deprez, Nicolas Triballeau, Piet Tom Bert Paul Wigerinck
  • Patent number: 8268885
    Abstract: The present invention relates to small molecules as entry inhibitors of the HIV virus, processes for their preparation as well as pharmaceutical compositions, their use as medicines, and diagnostic kits comprising them. The present invention also concerns combinations of the present entry inhibitors with other anti-retroviral agents. It further relates to their use in assays as reference compounds or as reagents. The compounds of the present invention are useful for preventing or treating infection by HIV and for treating AIDS.
    Type: Grant
    Filed: September 10, 2004
    Date of Patent: September 18, 2012
    Assignee: Janssen R&D Ireland
    Inventors: Koenraad Lodewijk August Van Acker, Piet Tom Bert Paul Wigerinck, Lieve Emma Jan Michiels, Abdellah Tahri
  • Publication number: 20120178718
    Abstract: Novel compounds are disclosed that have a Formula represented by the following: wherein X, R1, R2a, R2b, R2c, R3aR3b, R4a, R4b, R4c, and m1 are as described herein. The compounds may be prepared as pharmaceutical compositions, and may be used for the prevention and treatment of a variety of conditions in mammals including humans, including by way of non-limiting example, cachexia, osteoporosis, sarcopenia, a decline in libido and/or sexual dysfunction.
    Type: Application
    Filed: June 23, 2011
    Publication date: July 12, 2012
    Inventors: François Nique, Catherine Jagerschmidt, Florence Sylvie Namour, Roland Blanqué, Jean-Michel Lefrançois, Christophe Peixoto, Pierre Deprez, Nicolas Triballeau, Piet Tom Bert Paul Wigerinck
  • Patent number: 8143421
    Abstract: The present invention concerns the compounds having the formula N-oxides, salts, stereoisomeric forms, racemic mixtures, prodrugs, esters and metabolites thereof, wherein R1 and R8 each are H, optionally substituted C1-6alkyl, C2-6alkenyl, C3-7cycloalkyl, aryl, Het1, Het2; R1 may also be a radical of formula (R11aR11b)NC(R10aR10b)CR9—; t is 0, 1 or 2; R2 is H or C1-6alkyl; L is —C(?O)—, —O—C(?O)—, —NR8—C(?O)—, —O—C1-6alkanediyl-C(?O)—, —NR8—C1-6alkanediyl-C(?O)—, —S(?O)2—, —O—S(?O)2—, —NR8—S(?O)2; R3 is C1-6alkyl, aryl, C3-7cycloalkyl, C3-7cycloalkylC1-4alkyl, or arylC1-4alkyl; R4 is H, C1-4alkylOC(?O), carboxyl, aminoC(?O), mono- or di(C1-4alkyl)aminoC(?O), C3-7cycloalkyl, C2-6alkenyl, C2-6alkynyl or optionally substituted C1-6alkyl; A is C1-6alkanediyl, —C(?O)—, —C(?S)—, —S(?O)2—, C1-6alkanediyl-C(?O)—, C1-6alkanediyl-C(?S)— or C1-6alkanediyl-S(?O)2—; R5 is H, OH, C1-6alkyl, Het1C1-6alkyl, Het2C1-6alkyl, optionally substituted amino-C1-6alkyl; R6 is C1-6alkylO, Het1, Het1O, Het2, Het2O, aryl, arylO, C1-
    Type: Grant
    Filed: April 27, 2009
    Date of Patent: March 27, 2012
    Assignee: Tibotec Pharmaceuticals Ltd.
    Inventors: Dominique Louis Nestor Ghislain Surleraux, Piet Tom Bert Paul Wigerinck, Marieke Christiane Johanna Diepenbeek Voets, Sandrine Marie Helene Vendeville, Herman Augustinus De Kock, Bernhard Joanna Bernard Vergouwen
  • Patent number: 8119801
    Abstract: HIV replication inhibitors of formula pharmaceutically acceptable addition salts; or stereochemically isomeric forms thereof, wherein R1 is halo; R2 and R3 each independently are C1-6alkyl; pharmaceutical compositions containing these compounds as active ingredient and processes for preparing these compounds and compositions.
    Type: Grant
    Filed: January 20, 2010
    Date of Patent: February 21, 2012
    Assignee: Tibotec Pharmaceuticals Ltd.
    Inventors: Herman Augustinus De Kock, Piet Tom Bert Paul Wigerinck
  • Patent number: 8084494
    Abstract: The present invention concerns substituted aminophenylsulfonamide compounds, their use as protease inhibitors, in particular as broad-spectrum HIV protease inhibitors, processes for their preparation as well as pharmaceutical compositions and diagnostic kits comprising them. The present invention also concerns combinations of the present substituted aminophenylsulfonamide compounds with another anti-retroviral agent. It further relates to their use in assays as reference compounds or as reagents.
    Type: Grant
    Filed: November 28, 2006
    Date of Patent: December 27, 2011
    Assignee: Tibotec Pharmaceuticals Ltd.
    Inventors: Herman Augustinus De Kock, Tim Hugo Maria Jonckers, Stefaan Julien Last, Paul Jozef Gabriel Maria Boonants, Dominique Louis Nestor Ghislain Surleraux, Piet Tom Bert Paul Wigerinck